North America Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design, By Indication, By Service Type, By Sponsor, By Region, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                       1.1.1. Phase
                       1.1.2. Study Design
                       1.1.3. Indication
                       1.1.4. Regional scope
                       1.1.5. Estimates and forecast timeline
                   1.2. Research Methodology
                   1.3. Information Procurement
                       1.3.1. Purchased database
                       1.3.2. GVR’s internal database
                       1.3.3. Secondary sources
                       1.3.4. Primary research
                   1.4. Information or Data Analysis
                       1.4.1. Data analysis models
                   1.5. Market Formulation & Validation
                   1.6. Model Details
                       1.6.1. Commodity flow analysis (Model 1)
                           1.6.1.1. Approach 1: Commodity flow approach
                   1.7. List of Secondary Sources
                   1.8. List of Primary Sources
                   1.9. Objectives
                       1.9.1. Objective 1: Understanding the market dynamics
                       1.9.2. Objective 2: Understanding the market estimates and forecasts
                       1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
                       1.9.4. Objective 4: Understanding the key product and application scopes to conclude on the market size
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                   2.3. Competitive Insights
Chapter 3. Clinical Trials Market Variables, Trends & Scope
                   3.1. Market Lineage outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Penetration & Growth Prospect Mapping
                   3.3. Product Pipeline Analysis, by Stage
                       3.3.1. Therapeutics in development
                       3.3.2. Vaccines in development
                   3.4. Fast track of clinical trials
                   3.5. Solidarity clinical trials
                   3.6. Virtual clinical trials
                   3.7. COVID-19 impact on clinical trials
                   3.8. Market Dynamics
                       3.8.1. Market Driver Analysis
                       3.8.2. Market Restraint Analysis
                       3.8.3. Industry Challenges
                   3.9. Clinical Trials: Market Analysis Tools
                       3.9.1. Industry Analysis - Porter’s
                           3.9.1.1. Supplier Power
                           3.9.1.2. Buyer Power
                           3.9.1.3. Substitution Threat
                           3.9.1.4. Threat from new entrant
                           3.9.1.5. Competitive rivalry
                       3.9.2. PESTEL Analysis
                           3.9.2.1. Political Landscape
                           3.9.2.2. Environmental Landscape
                           3.9.2.3. Social Landscape
                           3.9.2.4. Technology Landscape
                           3.9.2.5. Legal Landscape
                       3.9.3. Major Deals & Strategic Alliances Analysis
Chapter 4. Clinical Trials Market: Segment Analysis, by Phase, 2018 - 2030 (USD Million)
                   4.1. Segment Dashboard
                   4.2. Phase market movement analysis, 2023 & 2030
                   4.3. Global Clinical Trials Market, by Phase, 2018 to 2030
                   4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       4.4.1. Phase I
                       4.4.2. Phase II
                       4.4.3. Phase III
                       4.4.4. Phase IV
Chapter 5. Clinical Trials Market: Segment Analysis, By Study Design, 2018 - 2030 (USD Million)
                   5.1. Segment Dashboard
                   5.2. Study Design Market Movement Analysis, 2023 & 2030
                   5.3. Global Clinical Trials Market, By Study Design, 2018 to 2030
                   5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       5.4.1. Interventional
                       5.4.2. Observational
                       5.4.3. Expanded Access
Chapter 6. Clinical Trials Market: Segment Analysis, By Indication, 2018 - 2030 (USD Million)
                   6.1. Segment Dashboard
                   6.2. Indication Market Movement Analysis, 2023 & 2030
                   6.3. Global Clinical Trials Market, By Indication, 2018 to 2030
                   6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       6.4.1. Autoimmune/inflammation
                       6.4.2. Pain management
                       6.4.3. Oncology
                       6.4.4. CNS condition
                       6.4.5. Diabetes
                       6.4.6. Obesity
                       6.4.7. Cardiovascular
                       6.4.8. Others
Chapter 7. Clinical Trials Market: Segment Analysis, Indication by Study Design, 2018 - 2030 (USD Million)
                   7.1. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       7.1.1. Autoimmune/inflammation
                           7.1.1.1. Interventional
                           7.1.1.2. Observational
                           7.1.1.3. Expanded Access
                       7.1.2. Pain management
                           7.1.2.1. Interventional
                           7.1.2.2. Observational
                           7.1.2.3. Expanded Access
                       7.1.3. Oncology
                           7.1.3.1. Interventional
                           7.1.3.2. Observational
                           7.1.3.3. Expanded Access
                       7.1.4. CNS condition
                           7.1.4.1. Interventional
                           7.1.4.2. Observational
                           7.1.4.3. Expanded Access
                       7.1.5. Diabetes
                           7.1.5.1. Interventional
                           7.1.5.2. Observational
                           7.1.5.3. Expanded Access
                       7.1.6. Obesity
                           7.1.6.1. Interventional
                           7.1.6.2. Observational
                           7.1.6.3. Expanded Access
                       7.1.7. Cardiovascular
                           7.1.7.1. Interventional
                           7.1.7.2. Observational
                           7.1.7.3. Expanded Access
                       7.1.8. Others
                           7.1.8.1. Interventional
                           7.1.8.2. Observational
                           7.1.8.3. Expanded Access
Chapter 8. Clinical Trials Market: Segment Analysis, by Sponsor, 2018 - 2030 (USD Million)
                   8.1. Segment Dashboard
                   8.2. Sponsor Market Movement Analysis, 2023 & 2030
                   8.3. Market Size, & Forecasts, 2018 to 2030:
                       8.3.1. Pharmaceutical & biopharmaceutical companies
                       8.3.2. Medical device companies
                       8.3.3. Others
Chapter 9. Clinical Trials Market: Regional Market Analysis, by region, 2018 - 2030 (USD Million)
                   9.1. Market Size, & Forecasts, 2018 to 2030:
                   9.2. North America
                       9.2.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
                       9.2.2. Market estimates and forecast, by phase, 2018 - 2030 (USD Million)
                       9.2.3. Market estimates and forecast, by study design, 2018 - 2030 (USD Million)
                       9.2.4. Market estimates and forecast, By Indication, 2018 - 2030 (USD Million)
                       9.2.5. U.S.
                           9.2.5.1. Market estimates and forecast, by phase, 2018 - 2030 (USD Million)
                           9.2.5.2. Market estimates and forecast, by study design, 2018 - 2030 (USD Million)
                           9.2.5.3. Market estimates and forecast, by indication, 2018 - 2030 (USD Million)
                           9.2.5.4. Market estimates and forecast, by sponsor, 2018 - 2030 (USD Million)
                       9.2.6. Canada
                           9.2.6.1. Market estimates and forecast, by phase, 2018 - 2030 (USD Million)
                           9.2.6.2. Market estimates and forecast, by study design, 2018 - 2030 (USD Million)
                           9.2.6.3. Market estimates and forecast, by indication, 2018 - 2030 (USD Million)
                           9.2.6.4. Market estimates and forecast, by sponsor, 2018 - 2030 (USD Million)

List of Tables

Table 1 List of abbreviation
Table 2 North America clinical trial market, by country, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
Table 3 North America clinical trial market, by phase, 2018 - 2030 (USD Million)
Table 4 North America clinical trials market, by study design, 2018 - 2030 (USD Million)
Table 5 North America clinical trials market, by indication, 2018 - 2030 (USD Million)
Table 6 North America clinical trials market, by service type, 2018 - 2030 (USD Million)
Table 7 North America clinical trials market, by sponsors, 2018 - 2030 (USD Million)
Table 8 US clinical trials market, by phase 2018 - 2030 (USD Million)
Table 9 US clinical trials market, by study design, 2018 - 2030 (USD Million)
Table 10 US clinical trials market, by indication, 2018 - 2030 (USD Million)
Table 11 US clinical trials market, by service type, 2018 - 2030 (USD Million)
Table 12 US clinical trials market, by sponsors, 2018 - 2030 (USD Million)
Table 13 Canada clinical trials market, by phase, 2018 - 2030 (USD Million)
Table 14 Canada clinical trials market, by study design, 2018 - 2030 (USD Million)
Table 15 Canada clinical trials market, by indication, 2018 - 2030 (USD Million)
Table 16 Canada clinical trials market, by service type, 2018 - 2030 (USD Million)
Table 17 Canada clinical trials market, by sponsors, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Clinical trials: market outlook
Fig. 10 Clinical trials competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 Clinical trials driver impact
Fig. 16 Clinical trials restraint impact
Fig. 17 Clinical trials strategic initiatives analysis
Fig. 18 Clinical trials: Phase movement analysis
Fig. 19 Clinical trials: Phase outlook and key takeaways
Fig. 20 Phase I market estimates and forecast, 2018 - 2030
Fig. 21 Phase II market estimates and forecast, 2018 - 2030
Fig. 22 Phase III market estimates and forecast, 2018 - 2030
Fig. 23 Phase IV market estimates and forecast, 2018 - 2030
Fig. 24 Clinical trials: study design movement analysis
Fig. 25 Clinical trials: study design outlook and key takeaways
Fig. 26 Interventional studies market estimates and forecasts, 2018 - 2030
Fig. 27 Expanded access studies market estimates and forecasts,2018 - 2030
Fig. 28 Clinical trials: Indication movement analysis
Fig. 29 Clinical trials: Indication outlook and key takeaways
Fig. 30 Autoimmune/inflammation market estimates and forecasts, 2018 - 2030
Fig. 31 Pain management market estimates and forecasts, 2018 - 2030
Fig. 32 Oncology market estimates and forecasts, 2018 - 2030
Fig. 33 Diabetes market estimates and forecasts,2018 - 2030
Fig. 34 Obesity market estimates and forecasts, 2018 - 2030
Fig. 35 Cardiovascular market estimates and forecasts,2018 - 2030
Fig. 36 Others market estimates and forecasts,2018 - 2030
Fig. 37 Clinical trials: service type outlook and key takeaways
Fig. 38 Protocol designing market estimates and forecast, 2018 - 2030
Fig. 39 Site identification market estimates and forecast, 2018 - 2030
Fig. 40 Patient recruitment market estimates and forecast, 2018 - 2030
Fig. 41 Laboratory services market estimates and forecast, 2018 - 2030
Fig. 42 Bioanalytical testing services market estimates and forecast, 2018 - 2030
Fig. 43 Clinical trial data management services market estimates and forecast, 2018 - 2030
Fig. 44 Others market estimates and forecast, 2018 - 2030
Fig. 45 Clinical trials: Sponsor movement analysis
Fig. 46 Clinical trials: Sponsor outlook and key takeaways
Fig. 47 Pharmaceutical& biopharmaceutical companies market estimates and forecast, 2018 - 2030
Fig. 48 Medical device companies market estimates and forecast, 2018 - 2030
Fig. 49 Others market estimates and forecast, 2018 - 2030
Fig. 50 North America market estimates and forecasts, 2018 - 2030
Fig. 51 U.S. market estimates and forecasts, 2018 - 2030
Fig. 52 Canada market estimates and forecasts, 2018 - 2030